{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["16(1)"],"submitter":["Yang HH"],"pubmed_abstract":["Objectives
To explore the short- and long-term effects of glycemic management-through glycemic treatment and blood glucose monitoring (BGM)-on stroke recurrence and mortality specifically in patients experiencing a first-ever ischemic stroke (FIS) with hyperglycemia (FISHG) who have not previously been diagnosed with diabetes mellitus (DM).Methods
We gathered data on patients who were registered on Taiwan's National Health Insurance Research Database from 2000 to 2015. We one-fold propensity-score-matched (by sex, age, and index date) 207,054 patients into 3 cohorts: those with FIS (1) without hyperglycemia, (2) hyperglycemia without glycemic treatment, and (3) hyperglycemia with glycemic treatment. We used Cox proportional hazard regression to evaluate the short- (within 1"],"journal":["Diabetology & metabolic syndrome"],"pagination":["302"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11657440"],"repository":["biostudies-literature"],"pubmed_title":["Impact of glycemic treatment and blood glucose monitoring on outcomes in patients with acute ischemic stroke without prior diabetes: a longitudinal cohort study."],"pmcid":["PMC11657440"],"pubmed_authors":["Lin TT","Wang BL","Chung CH","Huang YC","Yu PC","Yang HH","Yang CC","Chung RJ","Chen YJ","Huang SH","Chien WC","Liaw JJ","Chen PC"],"additional_accession":[]},"is_claimable":false,"name":"Impact of glycemic treatment and blood glucose monitoring on outcomes in patients with acute ischemic stroke without prior diabetes: a longitudinal cohort study.","description":"Objectives
To explore the short- and long-term effects of glycemic management-through glycemic treatment and blood glucose monitoring (BGM)-on stroke recurrence and mortality specifically in patients experiencing a first-ever ischemic stroke (FIS) with hyperglycemia (FISHG) who have not previously been diagnosed with diabetes mellitus (DM).Methods
We gathered data on patients who were registered on Taiwan's National Health Insurance Research Database from 2000 to 2015. We one-fold propensity-score-matched (by sex, age, and index date) 207,054 patients into 3 cohorts: those with FIS (1) without hyperglycemia, (2) hyperglycemia without glycemic treatment, and (3) hyperglycemia with glycemic treatment. We used Cox proportional hazard regression to evaluate the short- (within 1","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Dec","modification":"2025-04-22T10:44:58.973Z","creation":"2025-04-05T23:40:16.881Z"},"accession":"S-EPMC11657440","cross_references":{"pubmed":["39696458"],"doi":["10.1186/s13098-024-01542-2"]}}